News & Opinion - 2021
- – Health Affairs
New Medicare Technology Add-On Payment Could Be Used as a Market Support Mechanism to Accelerate Antibiotic Innovation
Despite growing antibiotic resistance, the development pipeline for antibiotics has slowed; Kevin Schulman and GSB alumni Neil Gandhi propose three approaches to encouraging funding and development.
- – BMJ Global Health
Novel strategies to support global promotion of COVID-19 vaccination
In this new paper, CERC’s Kevin Schulman asserts that consumer marketing practices in the US can boost Covid-19 vaccination rates globally – if they are adapted to local cultures.
- – IEEE Xplore
Smart Home Technologies Are Saving Money and Lives
By building "ambient intelligence" into places where at-risk individuals reside, CERC researchers are looking to improve outcomes while respecting privacy.
- – WSJ Opinion|Cpmmentary
A False Narrative About ‘Misinformation’ and Covid Vaccines
In this op-ed in The Wall Street Journal, Bob Kaplan writes that vaccine hesitancy is a pre-existing condition: "The internet is awash with misinformation about the vaccines. But data distortion seems to have little effect on vaccine uptake."
- – Stanford News Center
5 Questions: Kevin Schulman on whether taxpayers should pay for controversial new Alzheimer’s drug
CERC’s Kevin Schulman weighs in on the likely impact of the FDA’s approval of Aduhelm.